Short interest in CRISPR Therapeutics AG (NASDAQ:CRSP) decreased during the last reporting period, falling from 18.68M to 16.44M. This put 19.47% of the company's publicly available shares short.

Based on the recent average volume of 1.61M shares traded per day, it would take 10.23 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.